These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 15862291

  • 21. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, Takahashi H, Fukumoto H, Horiguchi T, Suzuki N, Shoji M.
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK, Verdile G, Bates KA, Martins RN.
    Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
    [Abstract] [Full Text] [Related]

  • 24. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
    Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, Refolo L, Petanceska S, Pappolla MA.
    Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vaccine for Alzheimer's disease?
    Health News; 2006 Oct; 12(10):2. PubMed ID: 17162790
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B.
    Vaccine; 2007 Apr 20; 25(16):3053-6. PubMed ID: 17287054
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain.
    Tamura Y, Hamajima K, Matsui K, Yanoma S, Narita M, Tajima N, Xin KQ, Klinman D, Okuda K.
    Neurobiol Dis; 2005 Nov 20; 20(2):541-9. PubMed ID: 15908227
    [Abstract] [Full Text] [Related]

  • 36. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
    Chauhan NB, Siegel GJ.
    Expert Rev Vaccines; 2004 Dec 20; 3(6):717-25. PubMed ID: 15606357
    [Abstract] [Full Text] [Related]

  • 37. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
    Subramanian S, Divya Shree AN.
    Neurosci Lett; 2008 May 09; 436(2):219-22. PubMed ID: 18394801
    [Abstract] [Full Text] [Related]

  • 38. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H.
    Rinsho Shinkeigaku; 2005 Nov 09; 45(11):867-9. PubMed ID: 16447748
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.